✦ LIBER ✦

Ex vivo activated memory T-Iymphocytes as adoptive cellular therapy of human renal cell tumour targets with potentiation by cis-diamminedichloroplatinum(II)

✍ Scribed by J.E. GOLD; T.R. MASTERS; B. BABBIT; E.M. FINE; H.N. WEBER; P.D. UNGER; I. LEVENTHAL; C.D. ZIPPE; M.E. OSBAND

Book ID: 115199126
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 723 KB
Volume: 76
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1995.tb07843.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ex vivo activated memory t-lymphocytes a

Ex vivo activated memory t-lymphocytes as adoptive cellular therapy of human soft-tissue sarcoma targets with potentiation by Cis-diamminedichloroplatinum (II)

✍ Jay E. Gold; Ted R. Masters; Norman D. Bloom; Michail K. Shafir; Michael J. Klei 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 959 KB

specificity in one patient. Restriction of ALT-cell lysis and IFN-y release against HLA-A2+ autologous and one allogeneic HLA-A2+ STS tumor target, but not other non-STS targets, was demonstrated in another patient. These data suggest that CDDP may help render STS susceptible to tumorspecific, immun

Adoptive cellular therapy of human breas

Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II)

✍ Dr. Jay E. Gold; Ira J. Bleiweiss; Alisan B. Goldfarb; Joel J. Bauer; Irwin M. G 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Autolymphocyte therapy (ALT) is adoptive cellular therapy of cancer using ex vivo activation of autologous peripheral blood lymphocytes (PBL). Memory T cells are the principal effector population in ALT, with in vivo activity in patients with metastatic renal cell carcinoma (RCC) and melanoma, and e